Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,322 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06841328Recruiting
Stem cell therapy for fertility in ovaries and testes
This study tests a regenerative stem cell therapy to improve fertility in men with testicular failure or low sperm count and women with early ovarian failure. It is for people who have already tried standard treatments without success.
Dubai, DubaiAges 20–50 - NCT06922344RecruitingPhase 4
Fluconazole vs Itraconazole for Pityriasis Versicolor
This study compares two common antifungal pills, fluconazole and itraconazole, to see which works better for treating pityriasis versicolor, a skin condition that causes discolored patches. If you have this condition and are generally healthy, you may be able to join.
Peshawar, KPKAges 18–50 - NCT05504941Recruiting
Testing a treatment target map in sudden brain bleeding
This study looks at a special scan (DSA, done with contrast dye) to find a likely “target” that doctors can use when treating sudden brain bleeding. It’s meant to help doctors better understand where treatment may be needed soon after symptoms start.
BaselAges 18 years+ - NCT06685887RecruitingPhase 2
Chemo, Immunotherapy, and Heated Belly Chemo for Stomach Cancer Spread
This trial tests combining standard chemotherapy and immunotherapy (tirelizumab) with heated chemotherapy given directly into the belly. It aims to treat stomach cancer that has spread to the abdominal lining, and may help shrink or control the cancer.
Wuhan, HubeiAges 18–75 - NCT06161805RecruitingPhase 3
Esketamine for chronic pain from endometriosis
This trial tests if esketamine, a nasal spray, can reduce chronic pelvic pain in women with endometriosis that hasn't improved with standard painkillers. You may qualify if you have severe pain and are scheduled for endometriosis surgery.
DelftAges 18–50 - NCT06877520Recruiting
Study of a new device for fixing leaky tricuspid valve
This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.
Tbilisi, K'alak'i T'bilisiAges 18 years+ - NCT06923150Recruiting
MiniGo vs. standard care for bowel symptoms after rectal cancer surgery
This trial tests a small, portable device called MiniGo that uses a gentle water rinse to help control bowel symptoms after rectal cancer surgery. It may be an option for people who still have bothersome bowel problems despite trying other treatments.
AmiensAges 18 years+ - NCT05028153RecruitingPhase 2
Azithromycin for young children with asthma-like hospital symptoms
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
Gentofte MunicipalityAges 1 year–5.9 years - NCT04997317RecruitingPhase 1/Phase 2
Lu-177 targeting drug for returning or growing meningioma
This Phase 1/2 study tests a targeted radioactive medicine (Lu-177-satoreotide) for meningiomas that keep coming back or keep growing. It works only if tumor imaging shows the tumor has the right “target” signal, and it aims to see how well it can control the disease and how safe it is.
Basel, Canton of Basel-CityAges 18 years+ - NCT05958563Recruiting
CPAP may prevent COPD flare-ups in COPD-OSA overlap
This study tests whether using continuous positive airway pressure (CPAP) can reduce acute COPD flare-ups in people who also have sleep apnea. It may help by improving breathing during sleep and lowering the chance of worsening lung symptoms.
AngersAges 40 years+ - NCT06480110RecruitingPhase 1/Phase 2
Ebastine plus docetaxel for advanced prostate cancer
This trial tests if combining the allergy drug ebastine with the chemotherapy docetaxel can help men with advanced prostate cancer that has stopped responding to hormone therapy. It may offer a new treatment option for those whose cancer is still growing.
CopenhagenAges 18 years+ - NCT06847126RecruitingPhase 3
Oral vs IV antibiotics for liver abscess treatment
This trial compares two antibiotic treatments for liver abscess: one given through an IV (into a vein) and one taken as pills by mouth. The goal is to see if the oral treatment works just as well, which could make treatment easier and more convenient for patients.
ChandigarhAges 18 years+ - NCT07210580Recruiting
Tracking symptoms to improve quality of life for veterans with IBD
This study tests whether a structured approach to tracking symptoms and adjusting care (called measurement-based care) can improve quality of life for veterans with IBD. It is for veterans whose IBD symptoms affect their daily life and who receive care at one of the four participating VA hospitals.
Decatur, GeorgiaAges 18 years+ - NCT07210606RecruitingPhase 4
Sleep apnea treatment study for veterans with heart failure
This study looks at how well a medicine called trazodone might help treat central sleep apnea in veterans who also have heart failure. It aims to improve sleep and breathing, which may help you feel better.
Detroit, MichiganAges 18 years+ - NCT07209358Recruiting
Study of a new treatment for diabetic foot ulcers
This trial tests a new product (EDX110) to help heal diabetic foot ulcers that haven't improved with standard care. It's for people with diabetes who have a non-infected or mildly infected ulcer on their foot.
Phoenix, ArizonaAges 18–90 - NCT07205328RecruitingPhase 2
Testing MT200605 for acute ischemic stroke
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
Beijing, Beijing MunicipalityAges 18–80 - NCT07211243Recruiting
Comparing two dressings for infected leg ulcers
This trial tests if a new version of a special dressing (Suprasorb X+PHMB Pro) works better than the current version for treating infected venous leg ulcers. It may help people with mildly to moderately draining wounds that are infected.
BialystokAges 18 years+ - NCT07205198RecruitingPhase 1
Study of SIBP-A10 for advanced solid tumors
This trial tests a new drug called SIBP-A10 for people with advanced cancer that has not responded to other treatments. It aims to see if the drug is safe and helps shrink tumors.
Dalian, LiaoningAges 18–75 - NCT07209761RecruitingPhase 3
New drug combo for drug-resistant TB (quabodepistat)
This study tests a new oral medication combination (quabodepistat with other drugs) for people with drug-resistant pulmonary TB. It aims to find a shorter, safer, and more effective treatment.
Beijing, Beijing MunicipalityAges 14 years+ - NCT05040178Recruiting
Study of Carbaglu® use for MMA and PA
This observational study looks at how Carbaglu® is used and how well it works for people with methylmalonic acidemia (MMA) or propionic acidemia (PA). It may help doctors understand real-world care for adults and children living with these conditions.
Washington D.C., District of ColumbiaAges Any age - NCT06723639Recruiting
Restoring the torn Achilles tendon
This trial is testing a new way to repair a completely torn Achilles tendon. It uses MRI scans to make sure the repair is as good as possible, aiming for better healing and recovery.
Copenhagen, CapitalAges 18–67 - NCT06928701Recruiting
Diet and exercise for early breast cancer before surgery
This trial tests whether a personalized nutrition and exercise program can improve treatment response by changing how your body and immune system react to breast cancer before surgery. It is for women newly diagnosed with early-stage breast cancer who will receive neoadjuvant therapy (treatment before surgery).
Novara, NovaraAges 18 years+ - NCT07208097Recruiting
Brain bleed clot dissolving with tNK for stroke recovery
This trial tests a clot-busting drug called tenecteplase given directly into the brain bleed through a thin tube. It may help reduce damage and improve recovery for people with a certain type of brain hemorrhage.
Suzhou, AnhuiAges 18–80 - NCT07209488Recruiting
Reading help after stroke
This study is for people who have trouble reading after a left-brain stroke. It tests a new way to help improve reading skills through practice and therapy.
Tallahassee, FloridaAges 18–85
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,322 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.